The contraception needs of the perimenopausal woman
| Autor: | Sarah M.R. Hardman, Ailsa E Gebbie |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
education.field_of_study
medicine.medical_specialty business.industry Obstetrics media_common.quotation_subject Population Obstetrics and Gynecology Fertility General Medicine medicine.disease Menopause Contraceptive use Transgender hormone therapy Hormonal contraception Family planning medicine education business Developed country media_common |
| Zdroj: | Best Practice & Research Clinical Obstetrics & Gynaecology. 28:903-915 |
| ISSN: | 1521-6934 |
| DOI: | 10.1016/j.bpobgyn.2014.05.006 |
| Popis: | Perimenopausal women have low fertility but must still be advised to use contraception until natural sterility is reached if they are sexually active. Patterns of contraceptive use vary in different countries worldwide. Long-acting reversible contraceptive methods offer reliable contraception that may be an alternative to sterilisation. Hormonal methods confer significant non-contraceptive benefits, and each individual woman should weigh up the benefits and risks of a particular method. No method of contraception is contraindicated by age alone, although combined hormonal contraception and injectable progestogens are not recommended for women over the age of 50 years. The intrauterine system has particular advantages as a low-dose method of effective hormonal contraception, which also offers control of menstrual dysfunction and endometrial protection in women requiring oestrogen replacement. Condoms are recommended for personal protection against sexually transmitted infections in new relationships. Standard hormone replacement therapy is not a method of contraception. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect